Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -7.61% | 38.78% | 2.37% | -- | |
| Total Depreciation and Amortization | -13.32% | 2.11% | -24.41% | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 873.24% | -13.89% | 54.65% | -4,048.33% | |
| Change in Net Operating Assets | -121.55% | -25.80% | -216.91% | 291.18% | |
| Cash from Operations | -3.53% | -16.17% | -42.05% | 82.40% | |
| Capital Expenditure | 71.17% | -8,960.58% | 42.62% | -41.25% | |
| Sale of Property, Plant, and Equipment | -100.74% | 143.46% | -- | 6,771.62% | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -372.24% | -762.53% | 622.68% | 75.62% | |
| Cash from Investing | -191.61% | -846.79% | 351.94% | 64.26% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 23.56% | -2.58% | 4.82% | -- | |
| Issuance of Common Stock | -100.00% | -25.00% | -93.10% | -42.11% | |
| Repurchase of Common Stock | -392,900.00% | -200.00% | 75.00% | 50.00% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -207.32% | 12.47% | |
| Other Financing Activities | -21.30% | -6.03% | -365.38% | -96.24% | |
| Cash from Financing | -131.33% | -9.82% | -201.31% | -2.43% | |
| Foreign Exchange rate Adjustments | -58.15% | 79.11% | 133.61% | 2.27% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -133.90% | -121.67% | -501.85% | 215.05% | |